Brewin Dolphin Wealth Management LTD Moderna, Inc. Transaction History
Brewin Dolphin Wealth Management LTD
- $917 Million
- Q2 2022
A detailed history of Brewin Dolphin Wealth Management LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 268 shares of MRNA stock, worth $8,752. This represents 0.0% of its overall portfolio holdings.
Number of Shares
268
Previous 268
-0.0%
Holding current value
$8,752
Previous $46,000
17.39%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding MRNA
# of Institutions
927Shares Held
256MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.32 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.27 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$835 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$574 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$239 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...